N Corvaïa - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

N Corvaïa

Showing results (21-30 of 30) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 30 results.

Infection and Immunity|September 13, 2001

Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniaeL Goetsch, A Gonzalez, H Plotnicky-Gilquin, et al.

The Journal of Peptide Research : Official Journal of the American Peptide Society|February 10, 2000

Synthesis and characterization of Respiratory Syncytial Virus protein G related peptides containing two disulfide bridgesA Beck, N Zorn, M C Bussat, et al.

Vaccine|July 18, 2001

A novel bipolar mode of attachment to aluminium-containing adjuvants by BBG2Na, a recombinant subunit hRSV vaccineN Dagouassat, V Robillard, J F Haeuw, et al.

Vaccine|March 21, 2001

Identification and characterisation of multiple linear B cell protectopes in the respiratory syncytial virus G proteinU F Power, H Plotnicky-Gilquin, L Goetsch, et al.

Vaccine|April 27, 2000

Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidateL Goetsch, H Plotnicky-Gilquin, T Champion, et al.

Biologicals : Journal of the International Association of Biological Standardization|February 20, 2002

Stability and CTL-activity of P40/ELA melanoma vaccine candidateA Beck, L Goetsch, T Champion, et al.

Journal of Virology|June 11, 1999

Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G proteinH Plotnicky-Gilquin, L Goetsch, T Huss, et al.

Vaccine|June 28, 2001

BBG2Na an RSV subunit vaccine candidate intramuscularly injected to human confers protection against viral challenge after nasal immunization in miceL Goetsch, H Plotnicky-Gilquin, J P Aubry, et al.

Journal of Immunological Methods|April 9, 2001

Development of a quantitative assay for residual host cell proteins in a recombinant subunit vaccine against human respiratory syncytial virusN Dagouassat, J F Haeuw, V Robillard, et al.

Vaccine|July 18, 2001

Lipophilic quaternary ammonium salt acts as a mucosal adjuvant when co-administered by the nasal route with vaccine antigensC Klinguer, A Beck, P De-Lys, et al.

Pageof 3

Search research articles

Showing results (21-30 of 30) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 30 results.

Infection and Immunity|September 13, 2001

Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniaeL Goetsch, A Gonzalez, H Plotnicky-Gilquin, et al.

The Journal of Peptide Research : Official Journal of the American Peptide Society|February 10, 2000

Synthesis and characterization of Respiratory Syncytial Virus protein G related peptides containing two disulfide bridgesA Beck, N Zorn, M C Bussat, et al.

Vaccine|July 18, 2001

A novel bipolar mode of attachment to aluminium-containing adjuvants by BBG2Na, a recombinant subunit hRSV vaccineN Dagouassat, V Robillard, J F Haeuw, et al.

Vaccine|March 21, 2001

Identification and characterisation of multiple linear B cell protectopes in the respiratory syncytial virus G proteinU F Power, H Plotnicky-Gilquin, L Goetsch, et al.

Vaccine|April 27, 2000

Biologicals : Journal of the International Association of Biological Standardization|February 20, 2002

Stability and CTL-activity of P40/ELA melanoma vaccine candidateA Beck, L Goetsch, T Champion, et al.

Journal of Virology|June 11, 1999

Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G proteinH Plotnicky-Gilquin, L Goetsch, T Huss, et al.

Vaccine|June 28, 2001

BBG2Na an RSV subunit vaccine candidate intramuscularly injected to human confers protection against viral challenge after nasal immunization in miceL Goetsch, H Plotnicky-Gilquin, J P Aubry, et al.

Journal of Immunological Methods|April 9, 2001

Development of a quantitative assay for residual host cell proteins in a recombinant subunit vaccine against human respiratory syncytial virusN Dagouassat, J F Haeuw, V Robillard, et al.

Vaccine|July 18, 2001

Lipophilic quaternary ammonium salt acts as a mucosal adjuvant when co-administered by the nasal route with vaccine antigensC Klinguer, A Beck, P De-Lys, et al.

Pageof 3